Tenaya Therapeutics (TNYA) Assets Average (2021 - 2026)

Tenaya Therapeutics' Assets Average history runs 6 years deep, the most recent figure standing at $141.0 million for Q1 2026.

• In Q1 2026, Assets Average rose 6.86% year-over-year to $141.0 million; the TTM figure through Mar 2026 stood at $141.0 million (up 6.86% YoY), while the FY2025 annual figure was $133.4 million, down 8.12% from the prior year.
• Assets Average was $141.0 million for Q1 2026 at Tenaya Therapeutics, up from $126.0 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $297.8 million in Q1 2022 to a low of $113.6 million in Q3 2025.
• Historically, Assets Average has averaged $189.6 million across 5 years, with a median of $177.7 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Assets Average slumped 32.21% in 2024, then climbed 6.86% in 2026.
• A 5-year view of Assets Average shows it stood at $252.6 million in 2022, then slipped by 27.97% to $182.0 million in 2023, then retreated by 28.41% to $130.3 million in 2024, then declined by 3.31% to $126.0 million in 2025, then grew by 11.95% to $141.0 million in 2026.
• The last three Assets Average figures came in at $141.0 million (Q1 2026), $126.0 million (Q4 2025), and $113.6 million (Q3 2025), per Business Quant data.